Φορτώνει......
Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Galcanezumab, along with three other monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway, represents the latest disease-specific and mechanism-based treatment for the prophylaxis of migraine. Galcanezumab shares data also for the prophylaxis of cluster head...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Neurol Disord |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7222235/ https://ncbi.nlm.nih.gov/pubmed/32426040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420918088 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|